your market intelligence analyst
Search Results
Edit Save
121,632 results
The selections or defaults defined for this collection may have been too restrictive for this search query. You can refine your results for this search.
GlobeNewswire 10/01/2020 16:01
CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, has entered into an employment agreement with a newly hired employee that, among other things, provides for the grant of a non-qualified stock option and of restricted stock units as inducements material to the employee entering into employment with Voyager.
Gladstone Institutes researchers in collaboration with researchers at UC San Francisco and the Technical University of Munich report that they say have mapped out the networks of genes that help differentiate regulatory T cells from other T cells. Their findings could lead to new immune therapies that treat cancer and autoimmune diseases. .

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.